Study of acquired hemolytic anemia in hospitalized adults
Treatments studied
Part of Blood & lymphatic clinical trials.
This study looks at adults who are in the hospital with acquired hemolytic anemia, a condition where the body destroys red blood cells too quickly. The goal is to understand this condition better and improve care for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with acquired hemolytic anemia (a condition where your body destroys red blood cells too quickly).
- You must be hospitalized in the Internal Medicine department at the time of diagnosis.
- You must not have an underlying cancer (other than a non-cancerous blood condition).
- You must not have a hereditary (inherited) form of hemolytic anemia, such as sickle cell disease or thalassemia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study helps doctors identify the genetic reason why some people have hemolytic anemia (a condition where red blood cells break down too quickly). Researchers will study patients with this condition and their family members to understand the underlying cause and potentially improve diagnosis and treatment.
This study looks at how autoimmune hemolytic anemia (when the body attacks its own red blood cells) relates to antiphospholipid syndrome (a condition that increases blood clot risk). It aims to better understand this connection, which may help improve care for people with both conditions.
This study looks at adults who come to the emergency department with low blood counts (anemia) that are not severe or life-threatening. It aims to better understand the causes of this condition so doctors can improve care.
This study looks at how hospitals manage your blood during and after planned surgeries that have a moderate to high risk of bleeding. It aims to find better ways to reduce blood loss and the need for transfusions.
This study observes adults hospitalized with a new or recent infection (symptoms started within 30 days). The goal is to learn more about how infections affect people in the hospital, without testing any new drugs or treatments.
This study is testing a new blood gas analyzer (ABL90 FLEX PLUS HEM) to see how well it works in adults. You may be able to join if you are 18 or older and a blood sample can be safely collected.
Hear when a new Hemolytic Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.